Fabrizio Fina

2.6k total citations · 2 hit papers
10 papers, 1.9k citations indexed

About

Fabrizio Fina is a scholar working on Automotive Engineering, Biomedical Engineering and Mechanical Engineering. According to data from OpenAlex, Fabrizio Fina has authored 10 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Automotive Engineering, 9 papers in Biomedical Engineering and 3 papers in Mechanical Engineering. Recurrent topics in Fabrizio Fina's work include 3D Printing in Biomedical Research (9 papers), Additive Manufacturing and 3D Printing Technologies (9 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (6 papers). Fabrizio Fina is often cited by papers focused on 3D Printing in Biomedical Research (9 papers), Additive Manufacturing and 3D Printing Technologies (9 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (6 papers). Fabrizio Fina collaborates with scholars based in United Kingdom, Spain and South Korea. Fabrizio Fina's co-authors include Simon Gaisford, Álvaro Goyanes, Abdul W. Basit, Atheer Awad, Christine M. Madla, Annalisa Martorana, Sarah J. Trenfield, Jiaxin Zhang, Wolfgang Mohr and Martin Rowland and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Pharmaceutics and Polymers.

In The Last Decade

Fabrizio Fina

10 papers receiving 1.9k citations

Hit Papers

Selective laser sintering (SLS) 3D printing of medicines 2017 2026 2020 2023 2017 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrizio Fina United Kingdom 9 1.6k 1.4k 472 172 112 10 1.9k
Pamela Robles Martinez United Kingdom 8 1.3k 0.8× 1.1k 0.8× 221 0.5× 163 0.9× 99 0.9× 9 1.6k
Rima Janusziewicz United States 8 1.4k 0.9× 1.4k 1.0× 367 0.8× 60 0.3× 141 1.3× 12 2.2k
Alice Melocchi Italy 25 1.6k 1.0× 1.3k 0.9× 617 1.3× 491 2.9× 290 2.6× 53 2.4k
Xiaoyan Xu China 17 1.0k 0.6× 847 0.6× 154 0.3× 130 0.8× 82 0.7× 50 1.6k
Francesco Briatico Vangosa Italy 20 810 0.5× 445 0.3× 433 0.9× 122 0.7× 171 1.5× 85 1.5k
Marco Uboldi Italy 15 618 0.4× 480 0.3× 272 0.6× 117 0.7× 114 1.0× 27 922
Guoqing Jin China 16 770 0.5× 407 0.3× 314 0.7× 81 0.5× 83 0.7× 40 1.5k
Yung‐Kang Shen Taiwan 18 465 0.3× 237 0.2× 438 0.9× 70 0.4× 81 0.7× 111 1.1k
David Brancazio United States 9 309 0.2× 377 0.3× 210 0.4× 47 0.3× 45 0.4× 10 715
Shen Luo China 7 471 0.3× 482 0.3× 121 0.3× 25 0.1× 84 0.8× 13 1.0k

Countries citing papers authored by Fabrizio Fina

Since Specialization
Citations

This map shows the geographic impact of Fabrizio Fina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Fina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Fina more than expected).

Fields of papers citing papers by Fabrizio Fina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Fina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Fina. The network helps show where Fabrizio Fina may publish in the future.

Co-authorship network of co-authors of Fabrizio Fina

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Fina. A scholar is included among the top collaborators of Fabrizio Fina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Fina. Fabrizio Fina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Awad, Atheer, Fabrizio Fina, Álvaro Goyanes, Simon Gaisford, & Abdul W. Basit. (2021). Advances in powder bed fusion 3D printing in drug delivery and healthcare. Advanced Drug Delivery Reviews. 174. 406–424. 167 indexed citations
3.
Awad, Atheer, Fabrizio Fina, Álvaro Goyanes, Simon Gaisford, & Abdul W. Basit. (2020). 3D printing: Principles and pharmaceutical applications of selective laser sintering. International Journal of Pharmaceutics. 586. 119594–119594. 265 indexed citations breakdown →
4.
Fina, Fabrizio, et al.. (2020). Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron. Pharmaceutics. 12(2). 110–110. 137 indexed citations
5.
Fina, Fabrizio, Álvaro Goyanes, Martin Rowland, Simon Gaisford, & Abdul W. Basit. (2020). 3D Printing of Tunable Zero-Order Release Printlets. Polymers. 12(8). 1769–1769. 46 indexed citations
6.
Awad, Atheer, Fabrizio Fina, Sarah J. Trenfield, et al.. (2019). 3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology. Pharmaceutics. 11(4). 148–148. 170 indexed citations
7.
Fina, Fabrizio, Álvaro Goyanes, Christine M. Madla, et al.. (2018). 3D printing of drug-loaded gyroid lattices using selective laser sintering. International Journal of Pharmaceutics. 547(1-2). 44–52. 205 indexed citations
8.
Fina, Fabrizio, Christine M. Madla, Álvaro Goyanes, et al.. (2018). Fabricating 3D printed orally disintegrating printlets using selective laser sintering. International Journal of Pharmaceutics. 541(1-2). 101–107. 231 indexed citations
9.
Goyanes, Álvaro, et al.. (2017). Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. International Journal of Pharmaceutics. 527(1-2). 21–30. 281 indexed citations
10.
Fina, Fabrizio, Álvaro Goyanes, Simon Gaisford, & Abdul W. Basit. (2017). Selective laser sintering (SLS) 3D printing of medicines. International Journal of Pharmaceutics. 529(1-2). 285–293. 421 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026